MKS (MKSI) Q2 2026 Earnings Call Transcript
MKS (MKSI) reported Q2 2026 revenue of $1.25 billion, up 28% year over year, with semiconductor revenue of $554 million (+28%), electronics and packaging revenue of $381 million (+44%), and specialty industrial revenue of $313 million (+14%). Non-GAAP EPS was $3.30 (+86%) and gross margin was 47.6%. Q3 revenue guidance is $1.35 billion midpoint.
How this was made
The 30-second read
Why it matters
Traders can update positioning based on the disclosed Q3 revenue midpoint, semiconductor growth outlook, margin/EBITDA performance, and the stated drivers of near-term margin pressure versus longer-term capacity benefits.
Market read
The transcript provides fresh, decision-relevant guidance and operational updates (Q3 revenue, semiconductor growth, AI chemistry mix, and capacity timelines) that can move expectations for earnings and margins.
What to watch
Capacity expansion timelines (Malaysia online in Q3 2027) and the reliance on WFE spending range ($200B-$250B) could create downside if end-market spending slows or if ramp costs persist longer than management expects.
Background
This is the Q2 2026 earnings call transcript for MKS (MKSI), covering results, guidance, and manufacturing/capacity plans across semiconductor equipment and chemistry.
Ticker impact
MKS guided Q3 revenue to $1.35B midpoint and expects semiconductor revenue to grow over 50% YoY, citing investment-ramp outperformance.
Bias toward upside for MKSI on guidance credibility, with potential volatility if investors focus on temporary margin headwinds.
The call discloses multiple forward-looking datapoints (Q3 revenue, semiconductor growth rate, AI chemistry mix, capacity online timing) plus a margin/EBITDA beat and a stated temporary gross margin headwind.
Market effects
Signals strength in WFE-linked deposition/etch and advanced packaging/AI chemistry demand, reinforcing a constructive read-through for semiconductor equipment supply chains.
Highlights Malaysia and China capacity expansion and a Germany restart, implying incremental regional capex and utilization dynamics into 2027.
Supports the broader AI investment cycle narrative by tying chemistry mix and service revenue step-up to high fab utilization and scaling requirements.
Counterpoint
The company explicitly flags a temporary gross margin headwind from equipment sales mix and facility ramp costs, which could limit upside if investors discount the “self-liquidating” claim.
Key entities
- companyMKS
Reported Q2 2026 results and provided Q3 guidance, including semiconductor growth expectations and margin/EBITDA performance.
- executiveJohn Lee
CEO who discussed advanced PCBs importance and reiterated the company’s WFE outperformance track record.
- executiveRam Mayampurath
CFO who addressed margin headwinds from ramp/equipment mix and discussed chemistry demand and capacity impacts.
